心肺運動測試市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，心肺運動測試市場規模將達到 38.7 億美元，到 2025 年將達到 40.6 億美元，到 2033 年將達到 58.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 4.7%。

心血管疾病是全球醫療保健領域日益嚴峻的挑戰，凸顯了有效診斷方案的緊迫性。數百萬人受心血管疾病影響，每年新增病例數居高不下，凸顯了早期發現和介入的必要性。這項迫切挑戰促使人們尋求綜合策略，包括整合心肺運動試驗等先進診斷方法。隨著醫療保健系統應對這些疾病日益沉重的負擔，注重預防措施至關重要。創新的檢測程序能夠促進早期診斷和治療，顯著改善患者預後，同時減輕醫療資源的壓力，成為應對這項重大公共衛生挑戰的關鍵工具。

心肺運動測試市場促進因素

全球心肺運動測試市場的主要促進因素之一是心血管和呼吸系統疾病盛行率的不斷上升。隨著肥胖和糖尿病等文明病的日益普遍，醫療機構擴大採用心肺運動測試來最佳化患者管理和製定個人化治療策略。這種先進的診斷方法提高了運動能力和呼吸功能評估的準確性，從而有助於改善臨床決策。此外，患者對預防性醫療保健重要性的認知不斷提高，也進一步推動了對這些測試服務的需求，進而促進了市場成長。

限制心肺運動測試市場的因素

全球心肺運動測試市場的主要阻礙因素之一是先進測試設備及其維護成本高。這可能會阻礙醫療機構，尤其是在發展中地區的醫療機構採用這些技術。此外，測試的複雜性以及操作設備和解讀結果所需的專業人員也可能限制其普及和應用。這導致部分市場缺乏標準化和認知度，從而限制了心肺運動測試的成長潛力。因此，採用此類測試服務所帶來的經濟負擔和營運挑戰可能會阻礙市場擴張和技術進步。

心肺運動測試市場趨勢

心肺運動測試市場正經歷顯著成長，這主要得益於技術進步和主要企業間的策略聯盟。產業巨頭不斷創新，提供各種運動測試系統，以提高診斷準確性並改善患者預後。醫療技術公司與呼吸分析等領域的專家之間的合作尤其重要，有助於將最尖端科技融入臨床實踐。這一趨勢反映了醫療保健行業為改善心肺評估所做的更廣泛的努力，最終推動了市場擴張，因為醫療保健機構越來越認知到綜合運動測試解決方案的價值。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球心肺運動測試市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 單光子發射電腦斷層掃描（SPECT）
• 心肺運動試驗（CPET）系統
• 心臟超音波圖
• 脈動式血氧監測儀系統
• 壓力血壓計
• 其他

全球心肺運動測試市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 氧氣攝入量
• 二氧化碳
• 分鐘通氣量
• 無氧閾值

全球心肺運動測試市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 診斷中心
• 門診治療中心
• 診所
• 醫院
• 其他

全球心肺運動測試市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• COSMED SRL（Italy）
• Nihon Kohden Corporation（Japan）
• Schiller AG（Switzerland）
• Masimo Corporation（USA）
• Cardinal Health（USA）
• SunTech Medical, Inc.（USA）
• Geratherm Medical AG（Germany）
• Spacelabs Healthcare（USA）
• Welch Allyn（USA）
• Microlife Medical Home Solutions Inc.（Swtzerland）
• Medisoft SA（Belgium）
• CAIRE Inc.（USA）
• Allengers（India）
• Cardioline SpA（Italy）
• Clarity Medical（India）
• Innomed Medical（Hungary）
• Valencell（USA）
• INTCO Medical Technology Co., Ltd.（China）

結論與建議

Cardiopulmonary Exercise Testing Market size was valued at USD 3.87 Billion in 2024 and is poised to grow from USD 4.06 Billion in 2025 to USD 5.86 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

Cardiovascular diseases pose a growing challenge for the global healthcare sector, highlighting the urgent need for effective diagnostic solutions. With millions of individuals affected by cardiovascular conditions, the current landscape reveals a high rate of new diagnoses each year, underscoring the necessity for early detection and intervention. This pressing issue drives the demand for comprehensive strategies that include the integration of advanced diagnostic methods, such as cardiopulmonary exercise testing. As healthcare systems grapple with the increasing burden of these diseases, the emphasis on proactive measures becomes paramount. By facilitating early diagnosis and treatment, innovative testing procedures can significantly improve patient outcomes while alleviating the strain on healthcare resources, positioning them as essential tools in tackling this critical public health challenge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segments Analysis

Global Cardiopulmonary Exercise Testing Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors and Others. Based on Application, the market is segmented into Oxygen Uptake, Carbon Dioxide, Minute Ventilation and Anaerobic Threshold. Based on End User, the market is segmented into Diagnostic Centers, Ambulatory Centers, Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cardiopulmonary Exercise Testing Market

One of the key market drivers for the global cardiopulmonary exercise testing market is the increasing prevalence of cardiovascular diseases and respiratory disorders. As lifestyle-related conditions such as obesity and diabetes become more common, healthcare providers are increasingly adopting cardiopulmonary exercise testing to optimize patient management and personalized treatment strategies. This advanced diagnostic approach allows for better assessment of exercise capacity and respiratory function, leading to improved clinical decision-making. Additionally, the growing awareness among patients regarding the importance of preventive healthcare measures further fuels demand for these testing services, thereby driving market growth.

Restraints in the Cardiopulmonary Exercise Testing Market

One significant restraint in the global cardiopulmonary exercise testing market is the high cost of advanced testing equipment and maintenance, which can deter healthcare facilities, especially in developing regions, from acquiring these technologies. Additionally, the complexity of the tests and the need for specialized personnel to operate equipment and interpret results may limit accessibility and adoption. This contributes to a lack of standardization and awareness in some markets, restraining the growth potential of cardiopulmonary exercise testing. Consequently, the financial burden and operational challenges associated with implementing such testing services can hinder market expansion and technological advancements.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is experiencing notable growth, driven by a combination of technological advancements and strategic collaborations among leading companies. Major industry players are continually innovating, offering a variety of exercise testing systems that enhance diagnostic accuracy and patient outcomes. Partnerships, such as those between medical technology firms and specialized companies in areas like breath analysis, are particularly influential, as they help integrate cutting-edge technologies into clinical practice. This trend reflects a broader commitment within the healthcare sector to improve cardiopulmonary assessments, ultimately propelling market expansion as healthcare providers increasingly recognize the value of comprehensive exercise testing solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cardiopulmonary Exercise Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Global Cardiopulmonary Exercise Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

Global Cardiopulmonary Exercise Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Centers
• Ambulatory Centers
• Clinics
• Hospitals
• Others

Global Cardiopulmonary Exercise Testing Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• COSMED SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunTech Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welch Allyn (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Medical Home Solutions Inc. (Swtzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisoft SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAIRE Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allengers (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardioline SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarity Medical (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innomed Medical (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valencell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INTCO Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations